Cellular cholesterol efflux and cholesterol loading capacity of serum: Effects of LDL-apheresis

Journal of Lipid Research

Volumn 53, Issue 5, 2012, Pages 984-989

  Adorni, M P ^a   Zimetti, F ^a   Puntoni, M ^b   Bigazzi, F ^c   Sbrana, F ^c   Minichilli, F ^b   Bernini, F ^a   Ronda, N ^a   Favari, E ^a   Sampietro, T ^b,c  

^a UNIVERSITY OF PARMA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

Author keywords

Cholesterol efflux capacity; Cholesterol loading capacity; Familial combined hyperlipidemia; Familial hypercholesterolemia; Low density lipoprotein

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; APHERESIS; ARTICLE; CELL TRANSPORT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; HUMAN CELL; LDL APHERESIS; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTIGENS, CD36; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BLOOD COMPONENT REMOVAL; CHOLESTEROL, LDL; DIFFUSION; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MACROPHAGES; MALE; MIDDLE AGED; TIME FACTORS; WATER;

EID: 84860272883     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P024810     Document Type: Article

References (27)

1. Masoura, C., C. Pitsavos, K. Aznaouridis, I. Skoumas, C. Vlachopoulos, and C. Stefanadis. 2011. Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis. Atherosclerosis. 214: 129-138.
2. Austin, M. A., C. M. Hutter, R. L. Zimmern, and S. E. Humphries. 2004. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am. J. Epidemiol. 160: 407-420. (Pubitemid 39166973)
3. Real, J. T., F. J. Chaves, I. Martinez-Uso, A. B. Garcia-Garcia, J. F. Ascaso, and R. Carmena. 2001. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia. Eur. Heart J. 22: 465-471. (Pubitemid 32619619)
4. Goldstein, J. L., W. R. Hazzard, H. G. Schrott, E. L. Bierman, and A. G. Motulsky. 1973. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J. Clin. Invest. 52: 1533-1543.
5. Rader, D. J., E. T. Alexander, G. L. Weibel, J. Billheimer, and G. H. Rothblat. 2009. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J. Lipid Res. 50 (Suppl.) : S189-S194.
6. Favari, E., M. Lee, L. Calabresi, G. Franceschini, F. Zimetti, F. Bernini, and P. T. Kovanen. 2004. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. J. Biol. Chem. 279: 9930-9936. (Pubitemid 38372593)
7. Dean, M., Y. Hamon, and G. Chimini. 2001. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. 42: 1007-1017. (Pubitemid 32645780)
8. de la Llera-Moya, M., M. A. Connelly, D. Drazul, S. M. Klein, E. Favari, P. G. Yancey, D. L. Williams, and G. H. Rothblat. 2001. Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J. Lipid Res. 42: 1969-1978.
9. Favari, E., L. Calabresi, M. P. Adorni, W. Jessup, S. Simonelli, G. Franceschini, and F. Bernini. 2009. Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1. Biochemistry. 48: 11067-11074.
10. Szczepiorkowski, Z. M., J. L. Winters, N. Bandarenko, H. C. Kim, M. L. Linenberger, M. B. Marques, R. Sarode, J. Schwartz, R. Weinstein, and B. H. Shaz. 2010. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J. Clin. Apher. 25: 83-177.
11. Orsoni, A., S. Saheb, J. H. Levels, G. Dallinga-Thie, M. Atassi, R. Bittar, P. Robillard, E. Bruckert, A. Kontush, A. Carrie, et al. 2011. LDL-apheresis depletes apoE-HDL and pre-beta1-HDL in familial hypercholesterolemia: relevance to atheroprotection. J. Lipid Res. 52: 2304-2313.
12. Kojima, S., M. Shida, H. Takano, S. Inami, K. Yodogawa, H. Yokoyama, and M. Kuramochi. 2001. Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis. Hypertens. Res. 24: 595-598. (Pubitemid 33048927)
13. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
14. Zanotti, I., E. Favari, and F. Bernini. 2012. Cellular cholesterol efflux pathways: impact on intracellular lipid trafficking and methodological considerations. Curr. Pharm. Biotechnol. 13: 292-302.
15. Jessup, W., I. C. Gelissen, K. Gaus, and L. Kritharides. 2006. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr. Opin. Lipidol. 17: 247-257. (Pubitemid 43786058)
16. Calabresi, L., E. Favari, E. Moleri, M. P. Adorni, M. Pedrelli, S. Costa, W. Jessup, I. C. Gelissen, P. T. Kovanen, F. Bernini, et al. 2009. Functional LCAT is not required for macrophage cholesterol efflux to human serum. Atherosclerosis. 204: 141-146.
17. Favari, E., I. Zanotti, F. Zimetti, N. Ronda, F. Bernini, and G. H. Rothblat. 2004. Probucol inhibits ABCA1-mediated cellular lipid efflux. Arterioscler. Thromb. Vasc. Biol. 24: 2345-2350. (Pubitemid 39658040)
18. Yancey, P. G., A. E. Bortnick, G. Kellner-Weibel, M. de la Llera- Moya, M. C. Phillips, and G. H. Rothblat. 2003. Importance of different pathways of cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23: 712-719.
19. Zimetti, F., G. K. Weibel, M. Duong, and G. H. Rothblat. 2006. Measurement of cholesterol bidirectional flux between cells and lipoproteins. J. Lipid Res. 47: 605-613. (Pubitemid 43345601)
20. Markwell, M. A., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210. (Pubitemid 9050428)
21. Rothblat, G. H., M. de la Llera-Moya, E. Favari, P. G. Yancey, and G. Kellner-Weibel. 2002. Cellular cholesterol flux studies: methodological considerations. Atherosclerosis. 163: 1-8.
22. Khera, A. V., M. Cuchel, M. de la Llera-Moya, A. Rodrigues, M. F. Burke, K. Jafri, B. C. French, J. A. Phillips, M. L. Mucksavage, R. L. Wilensky, et al. 2011. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N. Engl. J. Med. 364: 127-135.
23. Bellanger, N., A. Orsoni, Z. Julia, N. Fournier, E. Frisdal, E. Duchene, E. Bruckert, A. Carrie, D. Bonnefont-Rousselot, J. Pirault, et al. 2011. Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 31: 1675-1681.
24. Sampietro, T., M. Tuoni, M. Ferdeghini, A. Ciardi, P. Marraccini, C. Prontera, G. Sassi, M. Taddei, and A. Bionda. 1997. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation. 96: 1381-1385. (Pubitemid 27375325)
25. Chroni, A., T. J. Nieland, K. E. Kypreos, M. Krieger, and V. I. Zannis. 2005. SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. Biochemistry. 44: 13132-13143. (Pubitemid 41377293)
26. Matsuura, F., N. Wang, W. Chen, X. C. Jiang, and A. R. Tall. 2006. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J. Clin. Invest. 116: 1435-1442.
27. de la Llera-Moya, M., D. Drazul-Schrader, B. F. Asztalos, M. Cuchel, D. J. Rader, and G. H. Rothblat. 2010. The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler. Thromb. Vasc. Biol. 30: 796-801.